Cracking carboplatin resistance: Forward genetics identifies Hn1l/Jpt2 as a novel player in ovarian cancer’s escape from platinum therapy
Ovarian cancer (OC) remains the deadliest gynaecologic malignancy, with platinum-based chemotherapies such as carboplatin serving…